What began as a grassroots initiative has become embedded across Pfizer's research and manufacturing operations, helping reshape processes from Viagra to Paxlovid
Rebecca Trager is a Senior US Correspondent at Chemistry World. With a strong background in policy and a passion for journalism, she specializes in covering science policy, university research, and public policy, while also addressing themes related to climate change, healthcare, and wellness. Rebecca's work has been featured in Chemistry World, where she brings insights from her extensive experience in the field since 1997.